CD4 and coronary artery disorder: Consistently, accumulating evidence indicates that on evaluation of the feasibility of DCs and T cells as a diagnostic tool, the subsets of blood CD4+, CD8+, and CD4+CD25+Foxp3+T cells and the ratio of CD4 to CD8 cells hold promise as biomarkers of coronary artery disease (163).